News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AlphaRx International Holdings Limited Enters Oncology Market


10/18/2006 10:41:45 AM

HONG KONG -- (MARKET WIRE) -- October 18, 2006 -- AlphaRx International Holdings Limited ("AIH"), subsidiary of AlphaRx Inc. (OTCBB: ALRX), announces that they are entering into the multi billion dollars oncology market with two nanotechnology based products, to address hepatic and lung cancer respectively.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES